Advocates Seek Ban on Menthol Cigarettes and Flavored e-Cigarettes in Columbus

Oct.26.2022
Advocates Seek Ban on Menthol Cigarettes and Flavored e-Cigarettes in Columbus
Advocates call for ban on flavored tobacco products in Columbus stores to address marketing targeting vulnerable communities.

Health advocates are urging the Columbus City Council to ban the sale of menthol cigarettes and flavored electronic cigarettes in stores throughout the city.


Amanda Turner, the Executive Director of Tobacco 21, stated that the city council has not yet proposed any legislation, but the proposal is currently being drafted. Turner explained that this issue first arose approximately 18 months ago during a conversation with the Columbus Department of Public Health.


Dr. Phillip Gardner, a public health expert, has stated that 85 cities in the United States have already banned the sale of menthol cigarettes and flavored e-cigarettes, with an additional 300 cities recently banning the sale of flavored e-cigarettes. Gardner, who is co-chair of the African American Tobacco Control Leadership Council, also noted that Canada has a nationwide ban on the sale of menthol cigarettes.


Gardner and Turner stated that prohibiting the sale of these products in the city will begin to reverse the effects of decades of marketing aimed specifically at black people, other people of color, women, LGBTQ individuals, and other marginalized groups. Gardner said that the industry profits by using "disproportionate marketing and predatory plunder" to exploit vulnerable communities and make a profit.


According to him, tobacco marketers have discovered that promoting menthol cigarettes to black celebrities and athletes, even lowering their costs in communities with African Americans. Currently, 85% of black smokers use menthol cigarettes, while the same figure for white smokers is 30%. "In the early 1950s, only 5% of African Americans smoked menthol cigarettes. By 1968, this percentage had almost tripled to 14%. By 1976, it had tripled again to 42%," Gardner said.


He stated that despite critics suggesting that such a ban would only create an illegal market or push shoppers to other jurisdictions, the data indicates that this has not been the case in these areas. Turner further explained that the data shows that removing more addictive tobacco from the equation would aid individuals in quitting smoking.


Many individuals may switch products, but research indicates that if you are using menthol cigarettes and wish to quit smoking and switch to regular cigarettes, your chances of successfully quitting are higher because menthol is a flavoring. It is a cooling agent that can suppress coughing, Turner explained.


Gardner stated that this is "outrageous" because adding menthol makes people more susceptible to nicotine addiction and more difficult to quit. "Menthol is defined as an anesthetic that actually covers up the harsh taste of tobacco smoke. It has a numbing and cooling effect and allows for deeper inhalation. The deeper you inhale, the more toxins and nicotine you ingest," Gardner said. "The more nicotine and toxins you ingest, the more addicted you become. Quitting becomes even harder. That's why they put it in there. It's outrageous from the start.


Gardiner stated that the FDA is currently exploring the idea of banning the use of menthol in cigarettes, but the process would take too long. "The FDA is considering getting rid of menthol, but unfortunately, due to the FDA's delay, it is important for communities like Columbus to take action themselves. The FDA will need several years to accomplish this," he said.


Turner and Gardner stated that the ban would not prohibit products within the city, but only the sale of them. Therefore, individuals would not face trouble for purchasing and bringing them in from elsewhere. "These laws are about getting retailers to stop selling them and not about individuals using personal property or pursuing a percentage," said Gardner.


Critics say the ban is unfair to smokers who enjoy menthol or use flavored e-cigarettes as an alternative to traditional cigarettes. Some argue that it discriminates against Black smokers. In response, Gardner stated that "racists are not public health doctors, they're in the tobacco industry." "Indeed, it has been the tobacco industry that has been discriminatory, that has been racist," Gardner continued. "It is not the tobacco control movement that is trying to save lives.


When asked why health officials are taking action to prevent flavored tobacco instead of flavored alcohol, Gardner explained that occasional alcohol consumption, not including binge drinking, does not kill people. However, "if you use cigarettes as expected, 50% of people will die from smoking.


Cigarettes are more deadly. In fact, tobacco-related diseases are the leading cause of death in the world, including in the United States, Ohio, and unfortunately Columbus. This is the reality. We are working hard to save lives," Gardner said.


Art Way, a drug policy consultant who works with the tobacco industry, argues that focusing on smoking cessation is a more effective way to reduce nicotine addiction. Targeted bans like these, Way contends, are similar to "patronizing, drug war-type policies that do not benefit our communities.


Statement:


This article is based on compiled third-party information and is only intended for intra-industry communication and learning.


This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the truthfulness or accuracy of the content. The translation of this article is solely for industry research and communication purposes.


Due to limitations in translation abilities, the translated article may not express the same meaning as the original. Please refer to the original article for accuracy.


2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macao, Taiwan or foreign-related expressions and perspectives.


The copyright of the compiled information belongs to the original media and authors. If there is any infringement, please contact us to delete it.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
Cliff Douglas, a veteran U.S. tobacco-control and public health policy figure, told NAS 2026 that the “continuum of risk” should play a central role in tobacco policy. He called for clearer market pathways, stronger risk communication, differentiated regulation and enforcement, and said possible FDA reforms to PMTA reviews could be a “welcome correction” if they create a more efficient, predictable route for scientifically substantiated lower-risk products. Read 2Firsts’ on-site coverage.
Sep.26
F1 Faces Renewed Pressure Over Tobacco and Nicotine Sponsorships as 67 Groups Target ZYN and VELO Ahead of Madrid Race
F1 Faces Renewed Pressure Over Tobacco and Nicotine Sponsorships as 67 Groups Target ZYN and VELO Ahead of Madrid Race
Ahead of the Formula 1 race in Madrid, 67 Spanish and international public-health, medical and consumer organizations have sent an open letter to F1 President and CEO Stefano Domenicali calling for an end to sponsorships linked to the tobacco and nicotine industry, including nicotine pouches, vaping products and heated tobacco. The letter focuses on Philip Morris International’s ZYN partnership with Ferrari and British American Tobacco’s long-running partnership with McLaren and exposure for VELO. The campaign follows a March letter in which more than 160 organizations worldwide made a similar request to Formula 1.
Sep.10
German Customs Seize 115,800 Vapes in €1.4 Million Tax Case
German Customs Seize 115,800 Vapes in €1.4 Million Tax Case
Germany's Magdeburg Main Customs Office seized 115,800 untaxed e-cigarettes containing a combined 4.366 million mL of e-liquid during four truck inspections between August 10 and September 4, 2026. The seizures prevented an estimated €1.397 million in tax losses and set a record for the customs office's jurisdiction. Criminal proceedings have been initiated against four truck drivers. The case follows a separate German investigation involving more than 7.6 million illicit vapes and an estimated €33.3 million in excise-tax losses.
Enforcement
Oct.13
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
Less than a week after JUUL2 received U.S. FDA marketing authorization on August 28, 2026, JUUL Labs was sued for patent infringement in federal court in Delaware. AJ Marketing LLC filed the complaint on September 3, alleging that both JUUL 1 and JUUL2 infringe U.S. Patent No. 8,851,068 B2. The patent covers aspects of programmable electronic vaporization devices, including controls over dose delivery, usage frequency and operating parameters. The plaintiff is seeking reasonable royalties and ongoing royalties tied to the remaining life of the patent. JUUL has not yet publicly responded to the case.
Sep.10
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08
Charlie’s Bets on Age-Gating and 678 PMTA Assets as U.S. Vape Enforcement Landscape Shifts
Charlie’s Bets on Age-Gating and 678 PMTA Assets as U.S. Vape Enforcement Landscape Shifts
Charlie’s Holdings said in its latest shareholder letter that it is moving to commercialize PACHA products and monetize its PMTA assets as the FDA changes enforcement priorities for unauthorized ENDS products. Thirty PACHA SKUs were previously tentatively identified for a proposed public list of products that the FDA generally does not intend to prioritize for enforcement. Charlie’s is also preparing test-market sales of age-gated flavored disposables and says it currently holds 678 PMTA-related product assets while seeking additional strategic transactions and partnerships.
Sep.11